Anti-POPDC3 monoclonal antibody

Pre-made anti-POPDC3 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to POPDC3/POPDC3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1432-Ab-1/ GM-Tg-hg-IP1432-Ab-2Anti-Human POPDC3 monoclonal antibodyHuman
GM-Tg-rg-IP1432-Ab-1/ GM-Tg-rg-IP1432-Ab-2Anti-Rat POPDC3 monoclonal antibodyRat
GM-Tg-mg-IP1432-Ab-1/ GM-Tg-mg-IP1432-Ab-2Anti-Mouse POPDC3 monoclonal antibodyMouse
GM-Tg-cynog-IP1432-Ab-1/ GM-Tg-cynog-IP1432-Ab-2Anti-Cynomolgus/ Rhesus macaque POPDC3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1432-Ab-1/ GM-Tg-felg-IP1432-Ab-2Anti-Feline POPDC3 monoclonal antibodyFeline
GM-Tg-cang-IP1432-Ab-1/ GM-Tg-cang-IP1432-Ab-2Anti-Canine POPDC3 monoclonal antibodyCanine
GM-Tg-bovg-IP1432-Ab-1/ GM-Tg-bovg-IP1432-Ab-2Anti-Bovine POPDC3 monoclonal antibodyBovine
GM-Tg-equg-IP1432-Ab-1/ GM-Tg-equg-IP1432-Ab-2Anti-Equine POPDC3 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1432-Ab-1/ GM-Tg-hg-IP1432-Ab-2; GM-Tg-rg-IP1432-Ab-1/ GM-Tg-rg-IP1432-Ab-2;
GM-Tg-mg-IP1432-Ab-1/ GM-Tg-mg-IP1432-Ab-2; GM-Tg-cynog-IP1432-Ab-1/ GM-Tg-cynog-IP1432-Ab-2;
GM-Tg-felg-IP1432-Ab-1/ GM-Tg-felg-IP1432-Ab-2; GM-Tg-cang-IP1432-Ab-1/ GM-Tg-cang-IP1432-Ab-2;
GM-Tg-bovg-IP1432-Ab-1/ GM-Tg-bovg-IP1432-Ab-2; GM-Tg-equg-IP1432-Ab-1/ GM-Tg-equg-IP1432-Ab-2
Products NameAnti-POPDC3 monoclonal antibody
Formatmab
Target NamePOPDC3
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-POPDC3 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1432-Ag-1Recombinant multi-species POPD3/ POPDC3/ POP3 protein


    Target information

    Target IDGM-IP1432
    Target NamePOPDC3
    Gene ID64208,78977,641520,696377,100686841,101091447,100139174,100066315
    Gene Symbol and SynonymsbA355M14.1,LGMDR26,POP3,POPDC3
    Uniprot AccessionQ9HBV1
    Uniprot Entry NamePOPD3_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000132429
    Target ClassificationN/A

    The target: POPDC3, gene name: POPDC3, also named as POP3, bA355M14.1. This gene encodes a member of the POP family of proteins containing three putative transmembrane domains. This gene is expressed in cardiac and skeletal muscle and may play an important role in these tissues during development. Alternatively spliced transcript variants have been found. [provided by RefSeq, Nov 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.